| 000 | 02382 a2200637 4500 | ||
|---|---|---|---|
| 005 | 20250516145836.0 | ||
| 264 | 0 | _c20140131 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1755-3245 | ||
| 024 | 7 |
_a10.1093/cvr/cvt105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHosokawa, Susumu | |
| 245 | 0 | 0 |
_aPathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354. _h[electronic resource] |
| 260 |
_bCardiovascular research _cJul 2013 |
||
| 300 |
_a35-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChemokine CCL2 _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFamilial Primary Pulmonary Hypertension |
| 650 | 0 | 4 | _aFeedback, Physiological |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xgenetics |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xmetabolism |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xmetabolism |
| 650 | 0 | 4 | _aMonocrotaline |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aMyocytes, Smooth Muscle _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xgenetics |
| 650 | 0 | 4 |
_aTranscription Factor RelA _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVentricular Function, Right _xdrug effects |
| 650 | 0 | 4 |
_aVentricular Pressure _xdrug effects |
| 700 | 1 | _aHaraguchi, Go | |
| 700 | 1 | _aSasaki, Akihito | |
| 700 | 1 | _aArai, Hirokuni | |
| 700 | 1 | _aMuto, Susumu | |
| 700 | 1 | _aItai, Akiko | |
| 700 | 1 | _aDoi, Shozaburo | |
| 700 | 1 | _aMizutani, Shuki | |
| 700 | 1 | _aIsobe, Mitsuaki | |
| 773 | 0 |
_tCardiovascular research _gvol. 99 _gno. 1 _gp. 35-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cvr/cvt105 _zAvailable from publisher's website |
| 999 |
_c22712533 _d22712533 |
||